198 results
Autoimmune Gastritis - Pathophysiology

Anti-ParietaI Cell, CD4+ T Cells, Autoantibodies -> x Parietal Cells, x HCL, x
Autoimmune Gastritis - Pathophysiology ... Parietal Cells, x HCL ... Autoimmune #Gastritis #Pathophysiology
Mechanisms of Drug-Induced Hyperkalemia 
 • Direct renin inhibitor (Aliskiren)
 • Renin release inhibition (NSAIDs, Beta-Blockers)
Angiotensin-converting enzyme (ACE ... • Exogenous (KCL ... differential #diagnosis #pathophysiology
Iron Deficiency in Heart Failure
Pathophysiology:
Chronic heart failure leads to an increase in inflammatory cytokines → Inflammation
Heart Failure Pathophysiology ... Ferritin <100 ng/mL ... functional ID) Treatment ... composite endpoint of all-cause ... heartfailure #diagnosis #management
Hyperviscosity Syndrome - Causes and Treatment

 - Waldenstrom macroglobulinemia (most common) / Plasmapheresis 
 - Multiple
Syndrome - Causes and Treatment ... transformation (CML ... hyperleukocytosis (AML ... Differential #Diagnosis #Treatment ... #Management
Cyanide Toxicity 
Treatment:
1) Hydroxocobalamin + Cyanide = Cyanocobalamin (nontoxic) 
   or 
2) Amyl nitrite
Cyanide Toxicity Treatment ... Toxicity #Toxicology #Pathophysiology ... #Management #Treatment
Management of Medically Refractory Gastroparesis

Gastroparesis Pathophysiology
Initial Evaluation
Management
Medications for Medically Refractory Gastroparesis
Gastric Electrical Stimulation
Pylorus Directed Therapies

Dr. Chaitanya
Management of Medically ... Gastroparesis Pathophysiology ... Initial Evaluation Management ... Gastroparesis #Refractory #Management ... #Treatment #Gastroenterology
Tetralogy of Fallot Summary
 • Anatomy
 • Incidence
 • Pathophysiology
 • Presentation
 • Common Variants
 •
• Incidence • Pathophysiology ... palliation • Post-Op Management ... Fallot #diagnosis #management ... peds #pediatrics #treatment
Management of interstitial lung disease (ILD)-associated with systemic sclerosis (SSc)

Therapeutic indication: absolute decline in FVC >10%
Management of interstitial ... >10% (or >200 mL ... DLCO >15% (or 3 mL ... Symptomatic treatment ... #indications #management
Gastritis and Peptic Ulcer Disease - Etiology, Diagnostics, Treatment and Complications

#Diagnosis #Pathophysiology #Management #Gastritis #PepticUlcerDisease #PUD
, Diagnostics, Treatment ... #Diagnosis #Pathophysiology ... #Management #Gastritis
Rheumatoid Arthritis - ACR 2021 Guidelines
 - Low Disease Activity
 - Moderate to High Disease Activity
Rheumatoid Arthritis - ACR ... Tapering DMARDs - Treatment ... ACR2021 #Guidelines #management ... #treatment #rheumatology